Drug intelligence / Profile preview

CovalonGuard

Development stage
Unknown
Lead developer
Covalon Technologies
Modality
Small Molecules
Administration
Topical
01

Overview

**CovalonGuard** is a Covalon antimicrobial disinfectant and sanitizer product line rather than a single molecular drug entity. Publicly available information identifies at least two distinct products under this name: a **topical hand sanitizer spray** using **benzalkonium chloride** as the antimicrobial active, and a **hard-surface disinfectant solution** using **benzalkonium chloride plus didecyl dimethyl ammonium chloride**. The products were commercialized by **Covalon Technologies** around 2020, with Canada listings indicating approved disinfectant products and external distributor materials describing sustained antimicrobial barrier activity. Because the queried name maps to multiple specific formulations with different compositions and use settings, it is best treated as a non-specific branded disinfectant/sanitizer family rather than a single pharmaceutical drug.

Brand names
CovalonGuard
Other names
COVALONGUARDCOVALONGUARD SPRAYCOVALONGUARD SHIELD

Beyond the preview

Go deeper on CovalonGuard.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CovalonGuard.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call